Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Incannex Healthcare Stock Price, Quotes and Forecasts | NASDAQ:IXHL | Benzinga

Q: What sector and industry does Incannex Healthcare (IXHL) operate in?

Incannex Healthcare is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

Explore Incannex Healthcare stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IXHL.

Open	$0.74
Close	$0.70
Volume / Avg.	33.74K / 71.37K
Day Range	$0.70 - $0.75
52 Wk Range	0.72 - 3.60
Market Cap	$20.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	0.34%
Days to Cover	1.66

Recent News

Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies

Incannex Healthcare secures $60M in financing from Arena Investors to support clinical trials for cannabinoid and psychedelic therapies.

Patricio Liddle

FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety

FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, following a successful review of the IND application.

Juan Spínelli

FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder

Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of a pre-investigational new drug meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-O for the treatment of opioid use disorder (OUD).A number of FDA representatives shared insights on the CannQuit-O development program during the pre-IND teleconference in addition to providing recommendations on the proposed clinical development strategy.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.74
Close	$0.70
Volume / Avg.	33.74K / 71.37K
Day Range	$0.70 - $0.75
52 Wk Range	0.72 - 3.60
Market Cap	$20.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	0.34%
Days to Cover	1.66

About Incannex Healthcare Inc

Sector

Healthcare

Industry

N/A

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis produ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Incannex Healthcare (IXHL) stock?

You can purchase shares of Incannex Healthcare (NASDAQ:IXHL) through any online brokerage.

View our list of the best stock brokerages

Who are Incannex Healthcare (IXHL) competitors?

There are no as such competitors for Incannex Healthcare.

What is the forecast, or price target, for Incannex Healthcare (IXHL) stock?

There is no analysis for Incannex Healthcare to provide a consensus price target.

What is the current price for Incannex Healthcare (IXHL)?

The stock price for Incannex Healthcare (NASDAQ: IXHL) is $0.7398 last updated March 27, 2025 at 5:09 PM EDT.

Does Incannex Healthcare (IXHL) pay a dividend?

There are no upcoming dividends for Incannex Healthcare.

When is Incannex Healthcare (NASDAQ:IXHL) reporting earnings?

Incannex Healthcare’s Q3 earnings are confirmed for Wednesday, May 14, 2025.

Is Incannex Healthcare (IXHL) going to split?

There is no upcoming split for Incannex Healthcare.

What sector and industry does Incannex Healthcare (IXHL) operate in?

Incannex Healthcare is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

Comments

Incannex Healthcare Stock Price, Quotes and Forecasts

Incannex Healthcare (IXHL) Forecast